|
gptkbp:instanceOf
|
amphetamine
Hallucinogen
|
|
gptkbp:abusePotential
|
low
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:CASNumber
|
66142-81-2
|
|
gptkbp:category
|
Hallucinogen
entactogen
recreational drug
|
|
gptkbp:chemicalFormula
|
C10H14BrNO2
|
|
gptkbp:color
|
white (powder)
|
|
gptkbp:common_dose
|
12–24 mg (oral)
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:discoveredBy
|
gptkb:Alexander_Shulgin
|
|
gptkbp:duration_of_effects
|
4–8 hours
|
|
gptkbp:effect
|
euphoria
hallucinations
altered perception
empathogenic effects
|
|
gptkbp:featuredIn
|
gptkb:PiHKAL
gptkb:Erowid
|
|
gptkbp:firstSynthesized
|
1974
|
|
gptkbp:hasSMILES
|
COC1=CC(=C(C=C1CCN)OC)Br
|
|
gptkbp:hasStreet
|
Bees
Bromo
Bromo-mescaline
Toonies
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
2C-B
|
|
gptkbp:IUPACName
|
2-(4-bromo-2,5-dimethoxyphenyl)ethan-1-amine
|
|
gptkbp:legalStatus
|
gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(United_States)
gptkb:Class_A_(United_Kingdom)
illegal (many countries)
|
|
gptkbp:mechanismOfAction
|
serotonin receptor agonist
partial agonist at 5-HT2A receptor
|
|
gptkbp:meltingPoint
|
208–210 °C (hydrochloride salt)
|
|
gptkbp:molecularWeight
|
260.13 g/mol
|
|
gptkbp:PubChem_CID
|
16689
CHEMBL108325
|
|
gptkbp:relatedTo
|
gptkb:2C-E
gptkb:2C-I
mescaline
|
|
gptkbp:routeOfAdministration
|
oral
insufflation
|
|
gptkbp:sells
|
gptkb:Venus
gptkb:Nexus
Erox
|
|
gptkbp:toxicity
|
low (in humans, but not well studied)
|
|
gptkbp:UNII
|
QK8J339479
|
|
gptkbp:used_in_psychotherapy
|
yes (historically)
|
|
gptkbp:bfsParent
|
gptkb:2C-B-NBOMe-2,3-methylenedioxy
gptkb:NBOMe_series
gptkb:Alexander_Shulgin
gptkb:2C_family
gptkb:Hallucinogens
|
|
gptkbp:bfsLayer
|
7
|